MUMBAI, June 27 (Reuters) - India's Ranbaxy Laboratories rose 5.8 percent in early trading after the U.S. Food and Drug Administration said on Thursday it had approved the company's generic version of ...

BASEL (Reuters) - Swiss drugmaker Novartis reduced this year's sales forecasts on Wednesday, signalling it expected delayed generic competition to its once best-selling blood pressure pill Diovan in ...